Stage FocusSeed, Series A, Series B+
GeographyUS, Europe
TypeCVC
Last Activity2025
Industry Focus
Industries
BiotechSemiconductorsAdvanced MaterialsMedtechPhotonicsClimate TechNeurotechHardware
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
M Ventures is the strategic CVC of Merck KGaA (the German Merck, not the US pharmaceutical company), founded in 2009 with a €600M+ fund allocation. The firm has made 195 investments and developed 80+ companies from creation to exit.
The dual focus spans biotechnology (healthcare, life science tools) and technology (semiconductors, display). Portfolio companies include Tignis (AI for semiconductor...
Notable Investments
T
TignisM
MemryXSimilar Funds
S
SmartGateVC
Yerevan, Armenia
DeepTech NativeBiotechNeurotechAIPre-SeedSeed
BV
Blindspot Ventures
Boston, United States
DeepTech NativeEnergy TechAdvanced MaterialsQuantumPre-SeedSeed
HV
Hummingbird VC
London, United Kingdom
GeneralistBiotechAIBlockchainPre-SeedSeed
NV
Navigare Ventures
Stockholm, Sweden
Pure DeepTechBiotechSemiconductorsAdvanced MaterialsSeedSeries A
Osage University Partners
Bala Cynwyd, United States
DeepTech NativeBiotechMedtechClimate TechSeedSeries A
Parkwalk Advisors
London, United Kingdom
DeepTech NativeBiotechAIQuantumSeedSeries A